Sort
82,697 grants matching “vaccine development”
Human Respiratory Syncytial Virus Biology And Vaccine Development
$10,136,908Peter Leon Collins · Niaid Extramural Activities · Z01 · FY2007 · AI
Development and Production of Broadly Neutralizing HIV Antibodies
$10,120,321Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2025 · AI
Cancer Center Support Grant (Comprehensive)
$10,116,159Frederick R Appelbaum · Fred Hutchinson Cancer Research Center · P30 · FY2014 · CA
Development and Production of HIV Vaccines and Adjuvants
$10,098,321Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2025 · AI
Pacific-Southwest Ctr for Biodefense & Emerg Infect Dis*
$10,078,421Alan G. Barbour · University Of California-Irvine · U54 · FY2008 · AI
Cancer Center Support Grant (Comprehensive)
$10,072,717Frederick R Appelbaum · Fred Hutchinson Cancer Research Center · P30 · FY2013 · CA
CANCER AND LEUKEMIA GROUP B
$10,051,533University Of Chicago · U10 · FY2001 · CA
Clinical and Translational Science Center
$10,048,014Julianne L Imperato-McGinley · Weill Medical Coll Of Cornell Univ · UL1 · FY2022 · TR
Region VIII Research Center for Excellence for Biodefen*
$10,030,594John T Belisle · Colorado State University · U54 · FY2008 · AI
REGIONAL PRIMATE RESEARCH CENTER
$10,022,355University Of Washington · P51 · FY2000 · RR
Bioterrorism: Molecular Analysis and Intervention
$10,012,763Olaf Schneewind · University Of Chicago · U54 · FY2007 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs) Component A: Vaccine Center
$10,008,687Tony Moody · Duke University · N01 · FY2021 · AI
Addendum to HIV Active and Passive Clinical Material Manufacturing
$10,000,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER
$10,000,000Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2019 · AI
HIV Vaccine Research and Development
$10,000,000Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases · Y01 · FY2019 · AI
Development of a Third Generation Anthrax Vaccine
$10,000,000Pharmathene, Inc. · N01 · FY2008 · AI
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
$10,000,000Judith S. Currier · University Of California Los Angeles · UM1 · FY2022 · AI
Large scale T-Cell Epitope Discovery
$9,999,958Oregon Health & Science University · N01 · FY2009 · AI
Phase 2 Trial for Venezuelan Equine Encephalitis V3526
$9,996,228Dynport Vaccine Company, Llc · UC1 · FY2004 · AI
Pacific-Southwest Ctr for Biodefense &Emerg Infect Dis*
$9,980,000University Of California Irvine · U54 · FY2005 · AI
Region VIII Research Center for Excellence for Biodefen*
$9,980,000Colorado State University-Fort Collins · U54 · FY2005 · AI
Bioterrorism: Molecular Analysis and Intervention
$9,972,393Olaf Schneewind · University Of Chicago · U54 · FY2006 · AI
Clinical and Translational Science Center
$9,967,134Julianne L Imperato-McGinley · Weill Medical Coll Of Cornell Univ · UL1 · FY2023 · TR
Region VIII Research Center for Excellence for Biodefen*
$9,934,769John T Belisle · Colorado State University · U54 · FY2006 · AI
SERCEB Southeast Regional Centers of Excellence for Bio*
$9,920,891Philip Frederick Sparling · Duke University · U54 · FY2006 · AI